ON-TARGETplus Human LRRC8A (56262) siRNA - SMARTpool

siRNA / miRNA gene silencing Human - A2780 LRRC8A

Experiment
siRNA / miRNA gene silencing Human - A2780 LRRC8A
Product
ON-TARGETplus Human LRRC8A (56262) siRNA - SMARTpool from Horizon Discovery Ltd.
Manufacturer
Horizon Discovery Ltd.

Protocol tips

Protocol tips
Transient knock-down of A2780wt and A549wt cells was carried out using a pool of four siRNA LRRC8A (SMARTpool: ON-TARGETplus, GE Healthcare, Dharmacon), which has previous been used by Voss et al. (49) and siRNA p53 (SignalSilence p53, Cell signaling). MISSION Universal Negative Control siRNA (Sigma Aldrich) was used to create a baseline for knock-down efficiency. Cells grown to 40–50% confluence were transfected with LRRC8A or negative control (scramble) siRNA at a concentration of 25 nM using DharmaFECT-1 Transfection Reagent (Thermo Scientific). For p53 silencing A2780 cells were transfected with 10 nM, 25 nM, or 50 nM siRNA p53 for estimation of the minimal concentration. After 24 h incubation, the medium was replaced by transfection reagent-free medium, and the cells were left for another 24 h. Knockdown efficiency was estimated by Western blot analysis of LRRC8A and by its capability to reduce swelling-induced taurine efflux. In the case of siRNA p53 the cisplatin (10 μM, 24 h) induced increase in the p53 protein expression was found to be reduced to 24%, 31%, and 41% by 10 nM, 25 nM, or 50 nM siRNA p53, respectively. A concentration of 25 nM was chosen for p53 siRNA silencing.

Publication protocol

Transient knock-down of A2780wt and A549wt cells was carried out using a pool of four siRNA LRRC8A (SMARTpool: ON-TARGETplus, GE Healthcare, Dharmacon), which has previous been used by Voss et al. (49) and siRNA p53 (SignalSilence p53, Cell signaling). MISSION Universal Negative Control siRNA (Sigma Aldrich) was used to create a baseline for knock-down efficiency. Cells grown to 40–50% confluence were transfected with LRRC8A or negative control (scramble) siRNA at a concentration of 25 nM using DharmaFECT-1 Transfection Reagent (Thermo Scientific). For p53 silencing A2780 cells were transfected with 10 nM, 25 nM, or 50 nM siRNA p53 for estimation of the minimal concentration. After 24 h incubation, the medium was replaced by transfection reagent-free medium, and the cells were left for another 24 h. Knockdown efficiency was estimated by Western blot analysis of LRRC8A and by its capability to reduce swelling-induced taurine efflux. In the case of siRNA p53 the cisplatin (10 μM, 24 h) induced increase in the p53 protein expression was found to be reduced to 24%, 31%, and 41% by 10 nM, 25 nM, or 50 nM siRNA p53, respectively. A concentration of 25 nM was chosen for p53 siRNA silencing.

Full paper   Login or join for free to view the full paper.

Reviews

ON-TARGETplus Human LRRC8A (56262) siRNA - SMARTpool from Horizon Discovery Ltd. has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Start your discussion

Share your thoughts or question with experts in your field

Start a discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing siRNA / miRNA gene silencing Human - A2780 LRRC8A using ON-TARGETplus Human LRRC8A (56262) siRNA - SMARTpool from Horizon Discovery Ltd..

View full paper   Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from Horizon Discovery Ltd. for ON-TARGETplus Human LRRC8A (56262) siRNA - SMARTpool below.

Download PDF Download manufacturer protocol

Videos

Check out videos that might be relevant for performing siRNA / miRNA gene silencing Human - A2780 LRRC8A using ON-TARGETplus Human LRRC8A (56262) siRNA - SMARTpool from Horizon Discovery Ltd.. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms